Eckelman Brendan P. — SEC Form 4 filings
SEC reporting owner CIK 1766433. 5 Form 4 filings on record with FilingPulse; latest filed 2024-05-30.
Transaction summary — filings shown
Covers all 5 filings on record, filed 2024-03-12 to 2024-05-30. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 300,000 shares, $10,290,000 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 17.
- Largest priced transaction: sale of 300,000 shares @ $34.30 ($10,290,000) in Inhibrx, Inc., filed 2024-05-30.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Inhibrx, Inc. (INBX) | Chief Scientific Officer | 4 | — | 1 leg · 300,000 sh · $10,290,000 | 13 |
| Inhibrx Biosciences, Inc. (INXB) | Chief Scientific Officer | 1 | — | — | 4 |
Form 4 filings — Eckelman Brendan P.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2024-05-30 | 4 | Inhibrx, Inc. (INBX) | Sale (S): 300,000 @ $34.30 · Disposition to issuer (D): 1,735,553 @ $30 · Disposition to issuer (D): 160,000 @ $30 · Disposition to issuer (D): 160,000 @ $30 · Disposition to issuer (D): 6,667 (derivative) · Disposition to issuer (D): 26,667 (derivative) | EDGAR |
| 2024-05-30 | 4 | Inhibrx Biosciences, Inc. (INXB) | Grant/award (A): 433,888 · Grant/award (A): 40,000 · Grant/award (A): 40,000 · Grant/award (A): 175,000 (derivative) @ $0 | EDGAR |
| 2024-05-24 | 4 | Inhibrx, Inc. (INBX) | Option exercise (M): 2,510 (derivative) @ $34.12 · Option exercise (M): 2,500 (derivative) @ $34.12 | EDGAR |
| 2024-03-15 | 4 | Inhibrx, Inc. (INBX) | Option exercise (M): 1,898 (derivative) @ $35.33 | EDGAR |
| 2024-03-12 | 4 | Inhibrx, Inc. (INBX) | Option exercise (M): 2,150 (derivative) @ $35.75 · Option exercise (M): 6,877 (derivative) @ $35.30 · Option exercise (M): 6,681 (derivative) @ $35.33 · Option exercise (M): 19,898 (derivative) @ $35.25 · Option exercise (M): 4,152 (derivative) @ $35.25 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1766433 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →